User profiles for X. Puechal
Xavier PuechalVerified email at aphp.fr Cited by 22276 |
Whipple's disease
In 2000, Tropheryma whipplei was finally identified as the cause of Whipple's disease, a
chronic condition with protean manifestations that was first described in 1907. This review …
chronic condition with protean manifestations that was first described in 1907. This review …
Ocular inflammatory diseases associated with rheumatoid arthritis
…, A Brezin, L Guillevin, X Puechal - Nature Reviews …, 2014 - nature.com
The extra-articular complications of rheumatoid arthritis (RA) include ophthalmological
manifestations, which can, in some cases, be the first signs of the disease. These inflammatory …
manifestations, which can, in some cases, be the first signs of the disease. These inflammatory …
Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging
Y Allanore, O Vignaux, L Arnaud, X Puéchal… - Annals of the …, 2006 - ard.bmj.com
Background: Cardiac involvement in idiopathic inflammatory myopathy has been recognised
as an important prognostic factor, but treatment remains empirical. Objective: To investigate …
as an important prognostic factor, but treatment remains empirical. Objective: To investigate …
[HTML][HTML] Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
Background Current standard therapy for Wegener's granulomatosis and microscopic
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome
…, JF Cordier, P Delaval, X Puechal… - Annals of internal …, 2005 - acpjournals.org
Background: Since testing for antineutrophil cytoplasmic antibodies (ANCA) became
available for routine evaluation, no large homogeneous cohort of patients with the Churg–Strauss …
available for routine evaluation, no large homogeneous cohort of patients with the Churg–Strauss …
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)
Objective. There is no effective treatment for patients with primary Sjögren’s syndrome (SS).
Since tumor necrosis factor (TNF) could be a key element in the pathogenesis of primary SS, …
Since tumor necrosis factor (TNF) could be a key element in the pathogenesis of primary SS, …
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
…, AM Segal, C Ludivico, X Puechal… - Arthritis & …, 2002 - Wiley Online Library
Objective To evaluate treatment with methotrexate (MTX) in patients with newly diagnosed
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …
giant cell arteritis (GCA) to determine if MTX reduces GCA relapses and cumulative …
[HTML][HTML] Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis
…, CA Peh, WM Szpirt, X Puéchal… - … England Journal of …, 2020 - Mass Medical Soc
Background More effective and safer treatments are needed for antineutrophil cytoplasmic
antibody (ANCA)–associated vasculitis. Methods We conducted a randomized trial with a 2-by…
antibody (ANCA)–associated vasculitis. Methods We conducted a randomized trial with a 2-by…
Treatment of primary Sjögren syndrome with rituximab: a randomized trial
…, JM Berthelot, A Perdriger, X Puéchal… - Annals of internal …, 2014 - acpjournals.org
Background: Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial
JE Gottenberg, P Ravaud, X Puéchal, V Le Guern… - Jama, 2014 - jamanetwork.com
Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …